Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor
出版年份 2016 全文链接
标题
Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 113, Issue 41, Pages E6145-E6152
出版商
Proceedings of the National Academy of Sciences
发表日期
2016-09-27
DOI
10.1073/pnas.1607843113
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor
- (2016) Veit Rothhammer et al. NATURE MEDICINE
- CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands
- (2016) Bruno Lamas et al. NATURE MEDICINE
- AHR Function in Lymphocytes: Emerging Concepts
- (2016) Liang Zhou TRENDS IN IMMUNOLOGY
- Ultraviolet light converts propranolol, a nonselective β-blocker and potential lupus-inducing drug, into a proinflammatory AhR ligand
- (2015) Karim Dorgham et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function
- (2015) Jing Sun et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α
- (2015) Ivan D Mascanfroni et al. NATURE MEDICINE
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Aryl hydrocarbon receptor: Linking environment to immunity
- (2015) Marina Cella et al. SEMINARS IN IMMUNOLOGY
- Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis
- (2014) Michel Varrin-Doyer et al. EXPERIMENTAL NEUROLOGY
- Aryl Hydrocarbon Receptor Repressor and TiPARP (ARTD14) Use Similar, but also Distinct Mechanisms to Repress Aryl Hydrocarbon Receptor Signaling
- (2014) Laura MacPherson et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Laquinimod exerts strong clinical and immunomodulatory effects in Lewis rat experimental autoimmune neuritis
- (2014) Kalliopi Pitarokoili et al. JOURNAL OF NEUROIMMUNOLOGY
- A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
- (2014) T. L. Vollmer et al. JOURNAL OF NEUROLOGY
- The Aryl Hydrocarbon Receptor: Differential Contribution to T Helper 17 and T Cytotoxic 17 Cell Development
- (2014) Mark D. Hayes et al. PLoS One
- voom: precision weights unlock linear model analysis tools for RNA-seq read counts
- (2014) Charity W Law et al. GENOME BIOLOGY
- Aryl Hydrocarbon Receptor and Kynurenine: Recent Advances in Autoimmune Disease Research
- (2014) Nam Trung Nguyen et al. Frontiers in Immunology
- Immunological Relevance of the Coevolution of IDO1 and AHR
- (2014) Merja Jaronen et al. Frontiers in Immunology
- Laquinimod reduces neuroaxonal injury through inhibiting microglial activation
- (2014) Manoj Kumar Mishra et al. Annals of Clinical and Translational Neurology
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis
- (2013) Valérie Jolivel et al. BRAIN
- The roles of aryl hydrocarbon receptor in immune responses
- (2013) Nam Trung Nguyen et al. INTERNATIONAL IMMUNOLOGY
- Cross-talk between Aryl Hydrocarbon Receptor and the Inflammatory Response
- (2013) Christoph F. A. Vogel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage
- (2013) M. Filippi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Differential Influences of the Aryl Hydrocarbon Receptor on Th17 Mediated Responses in vitro and in vivo
- (2013) João H. Duarte et al. PLoS One
- Regulation of central nervous system autoimmunity by the aryl hydrocarbon receptor
- (2013) Francisco J. Quintana Seminars in Immunopathology
- Laquinimod Delays and Suppresses Nephritis in Lupus-Prone Mice and Affects Both Myeloid and Lymphoid Immune Cells
- (2013) Elaine V. Lourenço et al. Arthritis & Rheumatology
- Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis
- (2013) Spencer Moore et al. Brain and Behavior
- Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
- (2012) Wolfgang Brück et al. ACTA NEUROPATHOLOGICA
- Kinetics of Proinflammatory Monocytes in a Model of Multiple Sclerosis and Its Perturbation by Laquinimod
- (2012) Manoj K. Mishra et al. AMERICAN JOURNAL OF PATHOLOGY
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- GENCODE: The reference human genome annotation for The ENCODE Project
- (2012) J. Harrow et al. GENOME RESEARCH
- Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis
- (2012) Rina Aharoni et al. JOURNAL OF NEUROIMMUNOLOGY
- Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis
- (2012) Francesca Ruffini et al. Multiple Sclerosis Journal
- Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
- (2012) Giancarlo Comi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity
- (2012) Ulf Schulze-Topphoff et al. PLoS One
- Modulation of Autoimmune Demyelination by Laquinimod via Induction of Brain-Derived Neurotrophic Factor
- (2011) Jan Thöne et al. AMERICAN JOURNAL OF PATHOLOGY
- In Vivo Induction of Tr1 Cells via Mucosal Dendritic Cells and AHR Signaling
- (2011) Henry Yim Wu et al. PLoS One
- Exactly the Same but Different: Promiscuity and Diversity in the Molecular Mechanisms of Action of the Aryl Hydrocarbon (Dioxin) Receptor
- (2011) Michael S. Denison et al. TOXICOLOGICAL SCIENCES
- Hepatic transcriptomic responses to TCDD in dioxin-sensitive and dioxin-resistant rats during the onset of toxicity
- (2011) Paul C. Boutros et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis
- (2010) Christiane Wegner et al. JOURNAL OF NEUROIMMUNOLOGY
- The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27
- (2010) Lionel Apetoh et al. NATURE IMMUNOLOGY
- Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell–like and Foxp3+ regulatory T cells
- (2010) Roopali Gandhi et al. NATURE IMMUNOLOGY
- An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis
- (2010) F. J. Quintana et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
- (2008) Francisco J. Quintana et al. NATURE
- Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells
- (2008) A. Kimura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now